A Dose of Success: Marksans Pharma Receives UK Approval for Gabapentin Innovation

Unknown Apr 02, 2026 800 Views

Marksans Pharma's wholly owned subsidiary has attained an important regulatory milestone with marketing authorization for Gabapentin 50 mg/ml Oral Solution-a flagship product for the treatment of epilepsy and neuropathic pain. The approval, made by the UK's Medicines and Healthcare produc...